Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

LONDON MARKET OPEN: Earnings woe sends European stocks lower

25th Jul 2024 08:54

(Alliance News) - Stock prices in London opened lower on Thursday, with earnings from the UK and beyond largely falling short, after sentiment was already hurt by a tech sell-off in New York. Read More

LONDON BRIEFING: Astra ups outlook; Unilever and Lloyds back view

25th Jul 2024 07:49

(Alliance News) - London's FTSE 100 is called to open lower on Thursday, with a sell-off of US technology shares filtering through to trade in Europe and in Asia. Read More

UK earnings, trading statements calendar - next 7 days

19th Jul 2024 15:32

Read More

UK earnings, trading statements calendar - next 7 days

18th Jul 2024 16:07

Read More

AstraZeneca lofty revenue aim looks "readily deliverable" — Shore

12th Jul 2024 14:25

(Alliance News) - AstraZeneca PLC's recently announced aim of delivering USD80 billion in yearly revenue by the start of the next decade looks achievable, Shore Capital Markets said Friday, believing the drugmaker has an enviable pipeline. Read More

LONDON BROKER RATINGS: Barclays raises Kerry, cuts Hunting, Wood Group

10th Jul 2024 10:08

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

TOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer form

5th Jul 2024 08:36

(Alliance News) - AstraZeneca PLC on Friday announced that its medication osimertinib, alongside chemotherapy, has been approved by the European Commission. Read More

Aptamer shares jump as inks agreement with AstraZeneca

3rd Jul 2024 09:57

(Alliance News) - Aptamer Group PLC on Wednesday said it reached an agreement with AstraZeneca PLC. Read More

LONDON BROKER RATINGS: Deutsche Bank cuts Quilter, ups Polar Capital

2nd Jul 2024 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

TOP NEWS: AstraZeneca cancer and Covid drugs recommended for approval

1st Jul 2024 09:13

(Alliance News) - AstraZeneca PLC on Monday said two cancer treatments had been recommended for approval in the European Union, while there was also positive news for a Covid treatment. Read More

LONDON BRIEFING: Stocks called higher ahead of Thursday's election

1st Jul 2024 07:41

(Alliance News) - Stocks in London are called to open higher on Monday, at the start of a politically fuelled week. Read More

TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China

26th Jun 2024 08:40

(Alliance News) - AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day after a similar approval in Japan. Read More

Shore confident on AstraZeneca's Imfinzi despite recent study blow

25th Jun 2024 09:47

(Alliance News) - AstraZeneca PLC on Tuesday reported mixed results from probes of its key cancer drug Imfinzi, with the medication succeeding in a bladder cancer trial but falling short in non-small cell lung cancer. Read More

TOP NEWS: AstraZeneca details mixed findings from cancer drug trials

25th Jun 2024 09:05

(Alliance News) - AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso. Read More

LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake

25th Jun 2024 07:48

(Alliance News) - London's FTSE 100 is set to tread water on Tuesday, with a slump for US tech shares overnight keeping a lid on enthusiasm. Read More

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

20th Jun 2024 10:56

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslodex, for the treatment of a form of breast cancer. Read More

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

18th Jun 2024 09:33

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints. Read More

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

18th Jun 2024 07:51

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with inflation data and central bank decisions the key plot points as the week progresses. Read More

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

17th Jun 2024 09:09

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "important new option" for patients. Read More

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

17th Jun 2024 07:48

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Bank of England. Read More

FTSE 100 Latest
Value10,647.28
Change43.80